An enhanced expression of HIF-1α from normal tissue through premalignant lesions to carcinomas has already been observed in prostate [13], gastric [14], breast [15], oral cavity [16], cervical [17] and endometrial [18] carcinogenesis. Here, HIF1A is linked to carcinoma.